KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Liabilities from Discontinued Operations (2016)

Abbott Laboratories' Liabilities from Discontinued Operations history spans 5 years, with the latest figure at 245000000.0 for Q4 2016.

  • On a quarterly basis, Liabilities from Discontinued Operations fell 34.32% to 245000000.0 in Q4 2016 year-over-year; TTM through Dec 2016 was 245000000.0, a 34.32% decrease, with the full-year FY2016 number at 245000000.0, down 34.32% from a year prior.
  • Liabilities from Discontinued Operations hit 245000000.0 in Q4 2016 for Abbott Laboratories, up from 60000000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for ABT hit a ceiling of 721000000.0 in Q3 2014 and a floor of 1000000.0 in Q2 2014.
  • Historically, Liabilities from Discontinued Operations has averaged 252932187.5 across 4 years, with a median of 296500000.0 in 2015.
  • Biggest five-year swings in Liabilities from Discontinued Operations: plummeted 99.67% in 2014 and later soared 29100.0% in 2015.
  • Tracing ABT's Liabilities from Discontinued Operations over 4 years: stood at 386000000.0 in 2013, then crashed by 72.02% to 108000000.0 in 2014, then soared by 245.37% to 373000000.0 in 2015, then crashed by 34.32% to 245000000.0 in 2016.
  • Business Quant data shows Liabilities from Discontinued Operations for ABT at 245000000.0 in Q4 2016, 60000000.0 in Q3 2016, and 361000000.0 in Q2 2016.